Venn Life Sciences Holdings PLC Change of Adviser (9453T)
26 March 2019 - 6:01PM
UK Regulatory
TIDMVENN
RNS Number : 9453T
Venn Life Sciences Holdings PLC
26 March 2019
26 March 2019
Venn Life Sciences Holdings Plc
("Venn" or the "Company")
Change of Adviser
Venn Life Sciences, an Integrated Drug Development Partner
offering a combination of drug development expertise and clinical
trial design and management to pharmaceutical, biotechnology and
medical device organisations, announces the appointment of Arden
Partners plc as the Company's Nominated Adviser and Joint Broker
with immediate effect, alongside its existing Joint Broker and ESM
Adviser, Davy.
Enquiries:
Venn Life Sciences Holdings Plc Tel: +353 1 5499 341
Tony Richardson, Chief Executive Officer
Arden Partners (Nominated Advisor and Joint Broker) Tel: +44
(0)20 7614 5900
John Llewellyn-Lloyd / Ruari McGirr / Benjamin Cryer
Davy (ESM Adviser and Joint Broker) Tel: +353 (0)1 679 6363
Fergal Meegan / Matthew de Vere White (Corporate Finance)
About Venn Life Sciences
Venn Life Sciences is an Integrated Drug Development Partner
offering a unique combination of drug development expertise and
clinical trial design and management to pharmaceutical,
biotechnology and medical device organisations. Venn have dedicated
operations in France, Germany, the Netherlands, the UK, Ireland
with partners across Europe and the US.
Further information in relation to Venn Life Sciences
www.vennlifesciences.com
Venn life Science: getintouch@vennlife.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
APPDELFLKXFLBBQ
(END) Dow Jones Newswires
March 26, 2019 03:01 ET (07:01 GMT)
Hvivo (LSE:HVO)
Historical Stock Chart
From Apr 2024 to May 2024
Hvivo (LSE:HVO)
Historical Stock Chart
From May 2023 to May 2024